Patent details

EP1572729 Title: MUTANT FRPB PROTEIN AND REFOLDING METHOD

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1572729
WO Application Number:
EP2003009634
Type:
European Patent Granted for NL
Status:
Deemed not to be granted
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP03779785.9
WO Publication Number:
WO2004020463
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Belgium (BE)
Publications:

Dates

Filing date:
28/08/2003
Grant date:
22/09/2010
EP Publication Date:
22/09/2010
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
22/09/2010
EP B1 Publication Date:
22/09/2010
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
27/08/2023
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
22/09/2010
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
22/09/2010
 
 

 

Name:
GlaxoSmithKline Biologicals s.a.
Address:
rue de l'Institut 89, 1330 RIXENSART, Belgium (BE)

From:
22/09/2010
 
 

 

Name:
Utrecht University
Address:
Padualaan 8, 3584 CH, UTRECHT, Netherlands (NL)

From:
22/09/2010
 
 

 

Name:
Technology Foundation (Stichting voor de Technische Wetenschappen)
Address:
Van Vollenhovenlaan 661, 3527 JP, UTRECHT, Netherlands (NL)

Inventor

1

Name:
BIEMANS, Ralph, GlaxoSmithKline Biologicals S.A.
Address:
B-1330 RIXENSART, Belgium (BE)

2

Name:
DENOEL, Philippe, GlaxoSmithKline Biologicals S.A.
Address:
B-1330 RIXENSART, Belgium (BE)

3

Name:
FERON, Christiane, GlaxoSmithKline Biologicals SA
Address:
B-1330 RIXENSART, Belgium (BE)

4

Name:
GORAJ, Carine, GlaxoSmithKline Biologicals S.A.
Address:
B-1330 RIXENSART, Belgium (BE)

5

Name:
KORTEKAAS, Jeroen, Utrecht University
Address:
NL-3584 CH UTRECHT, Netherlands (NL)

6

Name:
POOLMAN, Jan, GlaxoSmithKline Biologicals S.A.
Address:
B-1330 RIXENSART, Belgium (BE)

7

Name:
TOMMASSEN, Jan, Utrecht University
Address:
NL-3584 CH UTRECHT, Netherlands (NL)

8

Name:
WEYNANTS, Vincent, GlaxoSmithKline Biologicals SA
Address:
B-1330 RIXENSART, Belgium (BE)

Priority

Priority Patent Number:
0220199
Priority Date:
30/08/2002
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 39/095;
IPC or IDT classification:
C07K 14/22; C07K 16/12; G01N 33/48;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
2011/06
Publication date:
09/02/2011
Description:
Lapse or annulment

2

Bulletin Heading:
EP2
Journal edition number:
2010/32
Publication date:
29/09/2010
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201038
Publication date:
22/09/2010
Description:
Grant (B1)
Filing date Document type Document Description Number of pages File Type